Helix BioPharma Corp. (HBP.TO)
1.99
-0.01
(-0.50%)
CAD |
TSX |
Feb 25, 16:00
Helix BioPharma Cash from Investing (Quarterly) : 0.00 for Oct. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Arch Biopartners, Inc. | 0.00 |
| Biocure Technology, Inc. | 0.00 |
| Resverlogix Corp. | -0.156M |
| Microbix Biosystems, Inc. | -0.1704M |
| Theratechnologies, Inc. | 0.0749M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.222M |
| Cash from Financing (Quarterly) | 1.655M |
| Free Cash Flow | -4.194M |
| Free Cash Flow Per Share (Quarterly) | -0.0161 |
| Free Cash Flow to Equity (Quarterly) | -1.239M |
| Free Cash Flow to Firm (Quarterly) | -1.211M |
| Free Cash Flow Yield | -3.33% |